References
- Conway DI, Stockton DL, Warnakulasuriya KAAS, Ogden G, Macpherson LMD. Incidence of oral and oropharyngeal cancer in the United Kingdom (1990–1999) – recent trends and regional variation. Oral Oncol 2006; 42: 596–2
- Franceschi S, Bidoli E, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000; 36: 106–15
- Salgado CJ, Mardini S, Chen H, Chen S. Critical oropharyngocutaneous fistulas after microsurgical head and neck reconstruction: indications for management using the tissue-plug technique. Plast Reconstr Surg 2003; 112: 957
- Friedman A, Potulska A. Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord 2001; 7: 329–32
- Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, et al. Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol 2002; 27: 18–22
- Monnier, G, Tatu, L, Parratte, B, Cosson, A, Michel, F, Metton, G. [Sialorrhea, hyperhidrosis and botulinum toxin.]. Ann Readapt Med Phys 2003;46:338–45, (in French).
- Arad A, Blitzer A. Botulinum toxin in the treatment of autonomic nervous system disorders. Head Neck Surg 2004; 15: 118–21
- Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg 2003; 61: 454–7
- Dogu O, Apaydin D, Sevim S, Talas DU, Aral M. Ultrasound-guided versus “blind” intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg 2004; 106: 93–6
- Malpani BL, Jaiswar RK, Samuel AM. Noninvasive scintigraphic method to quantify unstimulated secretions from individual salivary glands. Auris Nasus Larynx 1999; 26: 453–6